Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Aug 4, 2021, after the close
10-Q filed Aug 5, 2021, 36 days after period end · 0001564590-21-040986
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $115.22M | $110.10M | $83.21M | $57.06M |
| Net Income | -$43.87M | -$42.14M | -$54.94M | -$63.27M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.27 |
| -$0.27 |
| -$0.38 |
| -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
